Document is current
Any future updates will be listed below
-
Authors
Zeng, Leiping http://orcid.org/0000-0002-6421-0950
Liu, Yanxia
Nguyenla, Xammy Huu http://orcid.org/0000-0002-7532-8356
Abbott, Timothy R. http://orcid.org/0000-0001-7404-811X
Han, Mengting
Zhu, Yanyu http://orcid.org/0000-0001-8681-976X
Chemparathy, Augustine
Lin, Xueqiu
Chen, Xinyi
Wang, Haifeng
Rane, Draven A. http://orcid.org/0000-0001-9445-7260
Spatz, Jordan M.
Jain, Saket http://orcid.org/0000-0002-8655-2951
Rustagi, Arjun http://orcid.org/0000-0002-6921-1012
Pinsky, Benjamin http://orcid.org/0000-0001-8751-4810
Zepeda, Adrianna E.
Kadina, Anastasia P.
Walker, John A. III
Holden, Kevin http://orcid.org/0000-0002-3091-4124
Temperton, Nigel http://orcid.org/0000-0002-7978-3815
Cochran, Jennifer R. http://orcid.org/0000-0002-6532-9873
Barron, Annelise E. http://orcid.org/0000-0002-0735-6873
Connolly, Michael D. http://orcid.org/0000-0002-1817-8136
Blish, Catherine A. http://orcid.org/0000-0001-6946-7627
Lewis, David B.
Stanley, Sarah A.
La Russa, Marie F.
Qi, Lei S. http://orcid.org/0000-0002-3965-3223
-
Funding
Funding for this research was provided by:
Li Ka Shing Foundation
- License Information
-
More Information
Article History
Received: 28 October 2021
Accepted: 6 May 2022
First Online: 19 May 2022
Competing interests
: L.S.Q. is a founder and scientific advisory board member of Epicrispr Biotechnologies. A.E.Z., A.P.K., J.A.W., and K.H. are employees and shareholders of Synthego Corporation. C.A.B. reports compensation for consulting and/or SAB membership from Catamaran Bio, DeepCell Inc., Immunebridge, Sangamo Therapeutics, and Revelation Biosciences on topics unrelated to this study. The remaining authors declare no competing interests.
